2013
DOI: 10.1093/ndt/gft008
|View full text |Cite
|
Sign up to set email alerts
|

Imaging mass spectrometry: a new tool for kidney disease investigations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 54 publications
0
17
0
Order By: Relevance
“…81 Some of these include the study of anticancer drug distributions in mouse kidneys, 82 glomerular adenosine triphosphateadenosine monophosphate ratios in diabetic mouse models, 83 N -linked glycans in murine kidneys, 84 murine tubular lipid distributions in immunoglobulin A nephropathy, 85 region-specific sphingolipid metabolism in murine models of obesity, 86 sulfatide turnover in animal models of lipid storage disease, 87 sulfated lipid markers in polycystic kidney disease rats, 88 renal angiotensin metabolism in mice, 89 peptide classification and pathogenesis of amyloidosis in humans, 90 racial disparities in Wilms tumor incidence and human peptide biology, 91 rat protein biomarkers of gentamicin nephrotoxicity, 92 and assessing proteomic patterns of glomerulosclerosis for disease classification and prosclerotic mechanism determination in rats. 93 While it is impractical to provide a detailed description of all IMS renal research in this review, several recent reports are described below that highlight discoveries in areas of clear cell renal cell carcinoma, diabetic nephropathy (DN), preclinical renal drug toxicology, and infectious disease.…”
Section: Maldi Imaging Mass Spectrometry: a Molecular Microscope For mentioning
confidence: 99%
“…81 Some of these include the study of anticancer drug distributions in mouse kidneys, 82 glomerular adenosine triphosphateadenosine monophosphate ratios in diabetic mouse models, 83 N -linked glycans in murine kidneys, 84 murine tubular lipid distributions in immunoglobulin A nephropathy, 85 region-specific sphingolipid metabolism in murine models of obesity, 86 sulfatide turnover in animal models of lipid storage disease, 87 sulfated lipid markers in polycystic kidney disease rats, 88 renal angiotensin metabolism in mice, 89 peptide classification and pathogenesis of amyloidosis in humans, 90 racial disparities in Wilms tumor incidence and human peptide biology, 91 rat protein biomarkers of gentamicin nephrotoxicity, 92 and assessing proteomic patterns of glomerulosclerosis for disease classification and prosclerotic mechanism determination in rats. 93 While it is impractical to provide a detailed description of all IMS renal research in this review, several recent reports are described below that highlight discoveries in areas of clear cell renal cell carcinoma, diabetic nephropathy (DN), preclinical renal drug toxicology, and infectious disease.…”
Section: Maldi Imaging Mass Spectrometry: a Molecular Microscope For mentioning
confidence: 99%
“…Our method is a modified version of previous studies. 29,30 Cultured Rat Glomerular Endothelial Cells and Mesangial Cells…”
Section: Q16mentioning
confidence: 99%
“…Matrix-Assisted Laser Desorption/Ionization -Mass Spectrometry Imaging (MALDI-MSI) is a powerful technology that allows the evaluation of the spatial distribution and relative abundance of biomolecules directly on-tissue [1,2], without the need of any labeling or extraction processes that could compromise the molecular structure and mask the presence of altered expression of the analytes of interest, i.e. when these alterations are present in a small area of the tissue.…”
Section: Introductionmentioning
confidence: 99%
“…(1) At first, the structure of the data obtained from a MALDI-MSI analysis is explained, in order to make the reader aware of the needs and problematics related to the data and its processing, which is then presented more in detail. (2) Once the data has been processed to guarantee reproducibility and avoid artifacts, the data mining and elaboration phase is described by highlighting three of the most common processes for solving clinical problems: clustering, feature selection, and classification. (3) For each process, the basic statistic concepts are provided, along with examples of applications in the clinical practice and a tutorial to achieve the proposed aims via Orange Canvas and Weka.…”
Section: Introductionmentioning
confidence: 99%